PMID: 9418184Jan 7, 1998Paper

Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans

Journal of Clinical Immunology
S AggarwalS Gupta

Abstract

Aging is associated with progressive T cell-mediated immune deficiency, increased frequency of infections, and autoimmune phenomena. P-glycoprotein (P-gP), a 170-kDa glycoprotein, is a member of a superfamily of ATP-binding cassette transport proteins that has been shown to express on cells of the immune system and suggested to play a role in secretion of certain cytokines and cytotoxic molecules. Because aging is associated with altered secretion of cytokines, in this investigation we examined the expression and function of P-gP in CD4+ and CD8+ T cells and their "memory" and "naïve" subpopulations in peripheral blood from healthy aging and young subjects. P-glycoprotein expression was analyzed at the protein levels by dual- or triple-color flow cytometric analysis, using monoclonal antibodies against P-gP (MRK16), and at the mRNA level by quantitative reverse-transcriptase polymerase chain reaction. The efflux function of P-gP was measured by intracellular accumulation of rhodamine-123 (Rh123; a substrate for P-gP) in the presence or absence of cyclosporin A (which binds to P-gP and inhibits its efflux function). The data show increased expression of P-gP at both the protein and the mRNA levels in aging lymphocytes. Increased...Continue Reading

Citations

Jul 14, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R Aspinall
Jul 27, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Caroline Henrike StorchJohanna Weiss
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S OswaldH K Kroemer
Apr 7, 2010·Expert Opinion on Drug Metabolism & Toxicology·Carole GiraudJean-Marc Treluyer
Aug 29, 2007·DNA and Cell Biology·Bahareh Badrian, Marie A Bogoyevitch
Dec 7, 2007·Pflügers Archiv : European journal of physiology·Raphael C ValenteMárcia A M Capella
Dec 11, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C G MachadoR P Falcão
Nov 25, 2003·Microscopy Research and Technique·Richard Aspinall
Jul 13, 2004·Journal of Neuroscience Research·Thomas V GetchellMarilyn L Getchell
Sep 12, 2009·Journal of Leukocyte Biology·Rieneke van de VenRik J Scheper
Feb 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Neill James Liptrott, Andrew Owen
Mar 28, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Naoki InuiKingo Chida
Feb 6, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jill S WarringtonLisa L von Moltke
Nov 26, 2003·Scandinavian Journal of Immunology·B VitaleB Jaksić
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Arduino A Mangoni
Nov 24, 2004·Drug Metabolism Reviews·Ulrich Hoffmann, Heyo K Kroemer
Jul 26, 2005·Drugs & Aging·Christine E Staatz, Susan E Tett
Sep 10, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Vânia Vilas-BoasFernando Remião
Apr 11, 2019·Kidney Research and Clinical Practice·Cihan HeybeliTaner Camsari
Apr 20, 2001·Mechanisms of Ageing and Development·M SchiengoldN B Nardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.